Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 29, 2009Clinical Cancer ResearchOpen Access

Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks

View Full Paper
Ask AI
Bookmark
Share

Authors

DPDiane PalmieriNational Cancer InstitutePLPaul R. LockmanWest Virginia UniversityFTFancy ThomasTexas Tech University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Palmieri et al. (2009) studied this question.

synapsesocial.com/papers/6a71a412febe604dd70a3537https://doi.org/10.1158/1078-0432.ccr-09-1039
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses2007 · 723 citations
  2. 2Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis?2006 · 109 citations
  3. 3A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study2008 · 236 citations
  4. 4Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor2006 · 236 citations